NASDAQ: CRMD
Cormedix Inc Stock Ownership - Who owns Cormedix?

Insider buying vs selling

Have Cormedix Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joseph TodiscoChief Executive Officer2025-09-1250,000$13.00
$650.00kSell
Joseph TodiscoChief Executive Officer2025-09-1250,000$3.47
$173.50kBuy
Elizabeth HurlburtChief Operating Officer2025-09-1141,121$1.45
$59.63kBuy
Elizabeth HurlburtChief Operating Officer2025-09-1141,121$13.08
$537.86kSell
Kaufman Beth ZelnickChief Legal Officer2025-09-0950,000$3.30
$165.00kBuy
Kaufman Beth ZelnickChief Legal Officer2025-09-0949,600$13.41
$665.14kSell
Elizabeth HurlburtChief Operating Officer2025-09-0912,876$1.45
$18.67kBuy
Elizabeth HurlburtChief Operating Officer2025-09-0912,876$13.51
$173.95kSell
Kaufman Beth ZelnickChief Legal Officer2025-09-09400$12.82
$5.13kSell
Elizabeth HurlburtChief Operating Officer2025-08-298,424$14.83
$124.93kSell

1 of 4

CRMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRMD insiders and whales buy or sell their stock.

CRMD Shareholders

What type of owners hold Cormedix Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc7.90%5,359,829$69.36MInstitution
Vanguard Group Inc6.38%4,325,545$55.97MInstitution
Gary A. Gelbfish4.04%2,739,743$35.45MInsider
Marshall Wace LLP3.80%2,579,976$33.38MInstitution
Citadel Advisors LLC2.53%1,714,215$22.18MInstitution
State Street Corp2.36%1,601,648$20.73MInstitution
Geode Capital Management LLC2.35%1,596,322$20.66MInstitution
Nuveen LLC2.17%1,468,721$19.01MInstitution
Pharmabio Development Inc1.15%778,563$10.07MInsider
Morgan Stanley1.13%767,253$9.93MInstitution

1 of 3

CRMD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRMD50.35%10.06%Net SellingNet Selling
RAPP70.38%29.62%Net SellingNet Selling
URGN79.86%20.14%Net SellingNet Selling
ABUS29.81%70.19%Net Selling
ZBIO80.87%4.63%Net Buying

Cormedix Stock Ownership FAQ

Who owns Cormedix?

Cormedix (NASDAQ: CRMD) is owned by 50.35% institutional shareholders, 10.06% Cormedix insiders, and 39.59% retail investors. Gary A. Gelbfish is the largest individual Cormedix shareholder, owning 2.74M shares representing 4.04% of the company. Gary A. Gelbfish's Cormedix shares are currently valued at $35.45M.

If you're new to stock investing, here's how to buy Cormedix stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.